It Runs in the Family: What Genetics Tells Us About Back Pain and Disc Herniations

If your parent or grandparent suffered from chronic back pain, you may carry more than a sympathetic understanding of their condition; you may carry a genetic predisposition to it. A growing body of scientific research is clarifying what many clinicians have long suspected: the development of lumbar disc degeneration, disc herniation, and chronic low back pain is substantially influenced by inherited genetics, not merely lifestyle or injury.

What the Most Recent Research Shows

The genetic basis of lumbar disc disease has come into considerably sharper focus over the past three years. A landmark 2024 genome-wide association meta-analysis published in Nature Communications by Bjornsdottir et al., pooling data from the FinnGen, Estonian, and UK Biobank registries, identified 41 previously unreported genetic loci associated with lumbar disc herniation (LDH), in addition to 23 already established risk loci. Many of the newly identified loci harbor genes involved in disc structure (collagen networks), inflammation, and nerve function, suggesting that herniations reflect a convergence of structural vulnerability and neuroinflammatory predisposition.

In early 2025, an even larger multi-ancestry GWAS meta-analysis from the Million Veteran Program (Stanaway, Suri, et al., Nature Communications, 2025) examined 553,601 participants across African, European, and Hispanic ancestry groups and identified 67 novel genome-wide significant loci associated with chronic back pain. Notably, gene enrichment analysis pointed to brain and pituitary tissues, reinforcing the idea that chronic back pain is not purely a structural disorder; genetic factors that shape central sensitization and neurological pain processing are also inherited.

Twin registry data continue to strengthen the heritability argument. A 2024 Swedish twin study (Szigethy, Sigmundsson, Joelson, European Spine Journal) drew on national Swedish spine registry data spanning 1996–2022 to calculate concordance rates for surgically treated lumbar disc herniation and spinal stenosis in monozygotic versus dizygotic twin pairs. The findings confirmed a substantial heritable component for both conditions requiring operative intervention; a clinically significant threshold that earlier research had not isolated.

At the molecular level, collagen gene variants remain a critical focus. A 2024 case report from Zhejiang University (Jiang et al., Journal of Orthopaedic Surgery and Research) documented a four-generation pedigree in which a novel missense variant in COL9A3, a gene encoding Type IX collagen, critical to disc structural integrity, tracked with LDH onset across family members ranging in age from 14 to 35. The proband was a 14-year-old boy with L4/5 and L5/S1 herniations; his father, paternal aunt, and grandfather carried the same variant and the same diagnosis.

Recent Mendelian randomization studies published in 2024–2025 have added causal clarity to what had previously been associative evidence. Inflammatory cytokine pathways, sarcopenia-related traits, and plasma proteome signatures have all been shown to have causal genetic links to intervertebral disc degeneration, bridging the gap between inherited risk and potential therapeutic targets.

The Clinical Implication: Genes Are Not Destiny

Genetic predisposition does not equal inevitability. Environmental modifiers, body weight, physical conditioning, smoking cessation, ergonomic work habits, and avoidance of repetitive high-load spinal stress remain meaningful levers that individuals can act on. What the genetics literature tells us is that those with a positive family history carry a lower threshold for disc failure, meaning the same environmental exposures may produce more severe outcomes in them than in peers without that history. More importantly, some research suggests that while back pain has a genetic component, the need for back surgery may not.

Considerations If Back Pain Runs in Your Family

For individuals with a first-degree relative who has experienced chronic back pain, disc herniation, or lumbar surgery, several practical considerations warrant discussion with a spine-specialized physician:

•  Early symptom awareness: Do not normalize progressive back pain as “just aging.” Earlier clinical evaluation can identify disc changes at a stage where conservative management is most effective.

•  Core stability and weight management: These are the most evidence-based modifiable risk reducers for individuals with elevated genetic risk.

•  Imaging in appropriate context: Family history elevates the pre-test probability that imaging will reveal pathology. A frank discussion with your physician about MRI in the setting of persistent symptoms is reasonable.

•  Occupational and recreational planning: Careers or activities with high spinal loading carry a greater cumulative toll in genetically susceptible individuals.

•  Informing your family: If you have been diagnosed with significant disc pathology, sharing that information with adult children and siblings empowers them to take preventive steps.

The emerging genomics of spinal disease should not generate fatalism; it should generate informed action. Understanding your family’s spinal health history is as relevant to your preventive medicine profile as cardiovascular or oncologic family history. Your spine has a story. It is worth knowing.

References (2022–2025)

1.  Stanaway IB, Suri P, Afari N, et al.; Million Veteran Program. Multi-ancestry meta-analysis of genome-wide association studies discovers 67 new loci associated with chronic back pain. Nat Commun. 2025;16(1):1525. doi:10.1038/s41467-024-55326-3

2.  Bjornsdottir G, Sigurdardottir GR, Sveinbjornsson G, et al. Genome-wide meta-analysis conducted in three large biobanks expands the genetic landscape of lumbar disc herniations. Nat Commun. 2024;15(1):9640. doi:10.1038/s41467-024-53467-z

3.  Szigethy L, Sigmundsson FG, Joelson A. Surgically treated degenerative disk disease in twins. Eur Spine J. 2024;33(4):1381–1384. doi:10.1007/s00586-024-08161-5

4.  Jiang L, Wang C, Ye Z, Hu Q. A novel missense COL9A3 variant in a pedigree with multiple lumbar disc herniation. J Orthop Surg Res. 2024;19(1):19. doi:10.1186/s13018-023-04481-2

5.  Ou-Yang DC, Kleck CJ, Ackert-Bicknell CL. Genetics of intervertebral disc degeneration. Curr Osteoporos Rep. 2023;21(1):56–64. doi:10.1007/s11914-022-00769-0

6.  Ravichandran D, Pillai J, Krishnamurthy K. Genetics of intervertebral disc disease: a review. Clin Anat. 2022;35(1):116–120. doi:10.1002/ca.23803

7.  Xu Y, et al. Exploring causal correlations between inflammatory cytokines and intervertebral disc degeneration: a Mendelian randomization study. JOR Spine. 2024;7(3):e1349. doi:10.1002/jsp2.1349

8.  Qi W, Mei Z, Mao X, et al. Causal associations between sarcopenia-related traits and intervertebral disc degeneration: a two-sample Mendelian randomization analysis. Eur Spine J. 2024;33(6):2430–2438. doi:10.1007/s00586-024-08291-w

9.  Huang P, He Y, Zhi N, et al. Exploring upstream and downstream causality of inflammatory cytokines in intervertebral disc degeneration: a bidirectional, two-sample Mendelian randomization study. Eur Spine J. 2025;34:4558–4580. doi:10.1007/s00586-025-09005-6

www.shimspine.com  |  Case Chronology® Medicolegal Consulting  |  Oldsmar, Florida

This blog is intended for general informational purposes only and does not constitute medical advice. Consult a qualified spine specialist for evaluation and treatment recommendations.

Last modified: June 11, 2026